Eco Animal Health Group (LON:EAH) Receives “Buy” Rating from Peel Hunt

Peel Hunt reissued their buy rating on shares of Eco Animal Health Group (LON:EAH) in a report published on Monday morning, ThisIsMoney.Co.Uk reports.

Shares of LON:EAH opened at GBX 385 ($5.03) on Monday. Eco Animal Health Group has a 1-year low of GBX 90 ($1.18) and a 1-year high of GBX 755 ($9.87). The company has a debt-to-equity ratio of 1.76, a current ratio of 4.09 and a quick ratio of 3.04. The business has a fifty day moving average price of GBX 397.39 and a 200-day moving average price of GBX 412.53. The company has a market capitalization of $259.94 million and a PE ratio of 22.25.

The business also recently declared a dividend, which will be paid on Wednesday, October 16th. Stockholders of record on Thursday, September 26th will be issued a dividend of GBX 7.04 ($0.09) per share. The ex-dividend date of this dividend is Thursday, September 26th. This is an increase from Eco Animal Health Group’s previous dividend of $3.50. This represents a dividend yield of 1.96%. Eco Animal Health Group’s dividend payout ratio (DPR) is presently 0.87%.

Eco Animal Health Group Company Profile

ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.

Featured Story: How is the discount rate different from the Federal Funds rate?

Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with's FREE daily email newsletter.